A third of children with HIV virological rebound resuppress their virus without switching treatment
Latest News
STREAM TB trial recruits its 400th participant
STREAM TB trial recruits its 400th participant
US Food and Drug Administration approves once-daily use of abacavir and lamivudine for children with HIV
European Medicines Agency approves once-daily use of abacavir and lamivudine for children with HIV
BREATHER results on taking weekends off from HIV treatment presented at CROI Conference
BREATHER results on taking weekends off from HIV treatment presented at CROI Conference
PROUD study shows Pre-Exposure Prophylaxis is highly protective against HIV infection
PROUD study shows Pre-Exposure Prophylaxis is highly protective against HIV infection